查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2150673

EVA輸液袋市場報告：趨勢、預測及競爭分析（至2035年）

EVA Infusion Bag Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

EVA輸液袋市場

受醫院和診所市場機會的推動，全球EVA輸液袋市場前景光明。預計到2035年，全球EVA輸液袋市場規模將達到5.26億美元，高於2027年的3.23億美元，2027年至2035年的複合年成長率（CAGR）為6.1%。市場成長的主要促進因素包括靜脈注射需求的不斷成長、對更安全醫療包裝解決方案日益成長的需求以及一次性醫療產品的廣泛應用。

  • 根據 Lucintel 的預測，由於多腔袋與藥物具有更優異的相容性，且藥物分離更容易，因此預計在預測期內，多腔袋的成長率將更高。
  • 從應用角度來看，鑑於醫院進行的靜脈輸液治療程序數量不斷增加，預計「醫院」行業在預測期內將呈現更高的成長。
  • 從區域來看，亞太地區（APAC）預計將在預測期內呈現最高的成長率，這主要得益於醫院建設的增加和靜脈輸液療法的興起。

EVA輸液袋市場的新趨勢

預計在2025年至2027年間，EVA輸液袋市場將從通用輸液容器轉向針對不同市場應用客製化的系統。根據Lucintel的分析，這一轉變將受到一次性系統的推出、提取物監管更加嚴格以及對包裝系統永續性需求的推動。此外，人們可能會越來越傾向於在更接近消費終端的地方生產包裝系統。

  • 永續性：自2025年起，歐盟包裝指令將要求包裝材料製造商進一步減少包裝材料的使用量，並提高包裝的回收率。該指令可能促使醫療保健包裝（例如藥品包裝）更傾向於使用EVA薄膜和其他包裝材料。
  • 一次性生物製程：預計生物製藥產業在一次性生物製程系統中將更多地使用EVA袋。對加工過程中產品污染的擔憂可能會促使人們傾向於選擇一次性生物製程系統，即使這些系統是一次性的。
  • 功能客製化：在此期間，供應商將提供帶有額外隔離層的 EVA 袋，以保護袋內物品免受與其他藥品混合的影響以及溫度變化的不利影響。
  • 自動化和可追溯性：標籤、填充和檢驗的自動化流程正從大規模生產設施擴展到小規模生產設施，預計到2025年，整個製藥業將實現品質管理計畫的數位化。改進的自動化和可追溯性不僅有助於製藥公司在出貨環節中識別和減少錯誤，還有助於創建醫院所需的藥品「監管鏈」文件。
  • 為遵守法規，實現供應來源多元化：到2025年，製藥業除了現有的亞洲供應來源外，還將在北美和歐洲擁有多個醫療設備供應來源。董事會層級關注供應風險和監管柔軟性，將確保多元化供應策略的持續實施。

對於原料供應商而言，重點仍將放在在持續滿足性能要求的同時，改善環境影響。生物製藥行業願意為特定的功能改進付費。能夠整合多種供應和服務方案的供應商將更受規避風險的採購部門青睞。

EVA輸液袋市場的最新趨勢

預計到2027年，EVA輸液袋市場將持續成長。這主要得益於醫院和製藥公司為適應不斷變化的監管限制而做出的調整，以及醫院逐步淘汰PVC輸液袋。隨著對一次性輸液系統需求的不斷成長，Lucintel預測市場將向一次性輸液系統轉型。

  • 軟性EVA輸液袋：隨著費森尤斯卡比公司於2025年6月在美國擴大靜脈輸液產能，預計美國本土軟性EVA輸液袋的產量將會增加。未來3-5年內，美國將能夠生產軟性EVA輸液袋，降低對其他國家進口的依賴。
  • 一次性系統：材料供應商和包裝袋製造商正​​與生物製藥公司合作開發一次性系統。其中包括一項將於2025年（2025年3月）進行的合作，共同開發2000公升的一次性生物反應器。
  • 最新進展：首個採用多層EVA結構的輸液袋已實現商業化，該結構可提供3D阻隔氧氣和其他氣體的功能，並已宣布應用於500毫升輸液袋（預計2025年9月上市）。這種改良的氧氣阻隔性能將使EVA輸液袋可用於輸注較不穩定的藥物。
  • 法規核准：FDA正在加快容器和密封系統的審查。預計將對與藥品接觸的成分萃取物進行更廣泛的審查。競爭對手最早於2026年被要求提交驗證文件。 2026年2月，我們的供應商獲準向我們提供1000毫升EVA袋。預計此批准將有助於我們獲得更全面的文件，並簡化採購決策流程。
  • 永續性：目前正在進行評估，以減少一次性系統中的材料用量。例如，一項旨在將包裝袋重量減少15%的計劃（預計於2025年11月完成）。預計未來環境因素將在合約簽訂中發揮更重要的作用。其他因素，包括成本，預計也會影響合約決策。

EVA將用於製藥和醫療設備複合體以及其他需要符合VOCAL標準的PVC產品。隨著連續製藥和醫療設備複合體成為業界關注的焦點，EVA供應商將面臨與PVC供應商類似的挑戰。本地化生產能力以及更大、更穩定的業務基礎將有助於供應商贏得更清晰、大規模持久的市場。

目錄

第1章：執行摘要

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章：全球EVA輸液袋市場：按類型分類

  • 吸引力分析：按類型
  • 單室
  • 多重腔

第5章：全球EVA輸液袋市場：依應用領域分類

  • 吸引力分析：依目的
  • 醫院
  • 診所
  • 其他

第6章 區域分析

第7章：北美EVA輸液袋市場

  • 北美EVA輸液袋市場：按類型分類
  • 北美EVA輸液袋市場：依應用領域分類
  • 美國EVA靜脈輸液袋市場
  • 加拿大EVA靜脈輸液袋市場
  • 墨西哥EVA靜脈輸液袋市場

第8章：歐洲EVA輸液袋市場

  • 歐洲EVA靜脈輸液袋市場：按類型分類
  • 歐洲EVA輸液袋市場：依應用領域分類
  • 德國EVA靜脈輸液袋市場
  • 法國EVA靜脈輸液袋市場
  • 義大利EVA IV袋市場
  • 西班牙EVA靜脈輸液袋市場
  • 英國EVA靜脈輸液袋市場

第9章：亞太地區EVA輸液袋市場

  • 亞太地區EVA輸液袋市場：按類型分類
  • 亞太地區EVA輸液袋市場：依應用領域分類
  • 中國EVA輸液袋市場
  • 印度EVA靜脈輸液袋市場
  • 日本EVA靜脈輸液袋市場
  • 韓國EVA靜脈輸液袋市場
  • 印尼EVA輸液袋市場

第10章：世界其他地區EVA輸液袋市場

  • 其他地區EVA靜脈輸液袋市場：按類型分類
  • 其他地區EVA輸液袋市場：依應用領域分類
  • 中東EVA靜脈輸液袋市場
  • 南美洲EVA靜脈輸液袋市場
  • 非洲EVA靜脈輸液袋市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球EVA輸液袋市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • 競爭分析概述
  • Baxter International
  • B. Braun
  • Fresenius Kabi
  • Weigao Group
  • ICU Medical
  • Metrix
  • Technoflex
  • Bexen Medical
  • Eraser Medical
  • Valmed

第14章附錄

EVA Infusion Bag Market

The future of the global eva infusion bag market looks promising with opportunities in the hospital and clinic markets. The global eva infusion bag market is expected to reach an estimated $526 million by 2035 from $323 million in 2027 with a CAGR of 6.1% from 2027 to 2035. The major drivers for this market are the increasing demand for intravenous drug delivery, the rising need for safer medical packaging solutions, and the growing adoption of disposable medical products.

  • Lucintel forecasts that, within the type category, multi chamber is expected to witness higher growth over the forecast period due to more drug compatibility and separation with multi chamber bags.
  • Within the application category, hospital is expected to witness higher growth over the forecast period due to growing number of intravenous therapies delivered in hospital settings.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to more hospital construction and increase in intravenous therapies.

Emerging Trends in EVA Infusion Bag Market

In the years 2025 to 2027, the eva infusion bag market will transition from commodity fluid containers to customized systems for different market applications. Based on Lucintel's analysis, the transition will be due to the integration of single-use systems, increasingly stringent control of extractables, and a desire to improve the sustainability of packaging systems. Additionally, there will be a preference to manufacture packaging systems near the location of final consumption.

  • Sustainability: Starting from 2025, the EU packaging directives will require manufacturers of packaging materials to further reduce the volume of materials used in packaging and increase the recovery and recyclability of packaging. This directive will create a preference to use EVA films and other packaging materials in Healthcare Packaging to contain pharmaceuticals.
  • Single Use Bioprocessing: The biopharmaceutical industry will further increase the use of EVA bags in single use bioprocessing systems. Concern for product contamination during processing will create a preference for single-use bioprocessing systems, even if the systems are disposable.
  • Functional Customization: In the same period, suppliers will provide EVA bags with additional barrier layers to protect the contained contents from the effects of combination with other pharmaceuticals or from the adverse effects of change in temperature.
  • Automation and Traceability: Automated procedures for labeling, filling and inspecting are moving from large manufacturing facilities to smaller ones, and by 2025 the entire pharmaceutical industry is anticipated to digitize quality programs. Enhancements in automation and traceability will not only help pharmaceutical companies identify and reduce release errors, but also help them generate documentation required by hospitals for the "chain of custody" of pharmaceuticals.
  • Regulatory Supply Diversification: By 2025, the pharmaceutical industry will have added multiple supply sources for medical devices in both North America and Europe, in addition to existing sources in Asia. The focus on supply risk and regulatory flexibility at the board level will ensure continued multiple supply source strategies.

Continued emphasis will be placed on raw material suppliers to consistently meet performance requirements while also improving environmental impacts. The biopharmaceutical segment of the industry will be willing to pay for certain enhancements. Supply partners that can integrate multiple supply and service offerings will be favored by risk-averse procurement departments.

Recent Developments in the EVA Infusion Bag Market

The market for EVA infusion bags will grow through 2027, especially as hospitals and pharmaceutical companies respond to changing regulatory constraints, and as hospitals shift from using PVC. With increasing demand for single-use systems, Lucintel expects the market will shift to single-use systems.

  • Flexible EVA Infusion Bags: With the expansion of Fresenius Kabi's IV solution capacity in the U.S. in June 2025, the U.S. will have more local production of flexible EVA infusion bags. In the next 3 to 5 years, the U.S. will produce flexible EVA infusion bags and reduce the country's reliance on flexible EVA infusion bags from other countries.
  • Single-use Systems: Material suppliers and bag manufacturers will work with biopharmaceutical companies to develop single-use systems, including the 2025 collaboration to create a single-use bioreactor of 2,000 liters (March 2025).
  • New Developments: The first commercial use of a multi-layer EVA structure to provide a stereo-barrier for oxygen, and other gases, was announced for 500 ml. infusion bags (September 2025). The improved oxygen barrier will allow the use of EVA bags for infusion of more labile drugs.
  • Regulatory Approval: The FDA is accelerating its review of container closure systems. A broader review of the extractables of components in contact with drugs is anticipated. Our competition was required to provide validation in 2026 for the first time. A supply mate received approval to provide us a 1,000 mL EVA bag in February 2026. This approval would provide better documentation and facilitate our purchasing decisions.
  • Sustainability: There are ongoing assessments to reduce the use of materials in single use systems. One such assessment was to reduce the weight of a bag by 15% (November 2025). We expect that environmental friendliness will become an more important consideration in contracting. Other considerations, including cost, will also influence contracting decisions.

Drug/device combination products and other products that require PVC to be Vocal compliant will use EVA. Continuous drug/device combination products will be the focus of the industry, and suppliers of EVA will have the same challenges as PVC suppliers. The ability to produce locally and have larger, more established operations will help vendors capture a more defined and larger permanent market.

Strategic Growth Opportunities in the EVA Infusion Bag Market

The eva infusion bag market is expected to expand from 2024 to 2026 with increased adoption by hospitals, closure of systems by manufacturers and reduction in the use of PVC by manufacturers. Meanwhile, drug shortages, outsourcing of pharmaceutical manufacturing and shift to home-based care increase the demand for infusion therapy. According to Lucintel, customer value lies in application-specific infusion therapy as opposed to generic infusion bags.

  • Advanced Drug Delivery: The demand for infusion bags for biologics and oncology and other products which require special consideration like oxygen sensitivity is anticipated to increase. In the absence of such products, pharmacy and other healthcare providers are forced to use infusion bags for compounding and storage of such products which increase the demand for drug shortage, and in turn encourage the use of infusion bags for specialized drug formulations.
  • Home Infusion: Special consideration infusion therapy products and services can be used for home health care. The Centers Medicare and Medicaid Services estimated that as of January 2025, there were 1.5 million beneficiaries using home health care services. The agencies which provide home health care products and services that reduce the complexity of infusion therapy will be used and purchased by pharmacies and other healthcare institutions.
  • New Markets: Growing demand for IV therapies in India, S.E. Asia, Latin America, and other growth markets provides an opportunity to establish local production and distribution. India's pharma exports to 214 countries in April 2025, offers potential for infusion systems manufacturers to source flexible, compatible packages. The ability and timeframe to gain local acceptance for infusion systems will dictate market entry.
  • New Materials: The EU's Packaging Directive and other similar legislation will drive the adoption of infusion systems based on the principles of sustainable development, materials efficiency, and longer term use of infusion systems. Additionally, Infusion systems manufacturers will be required to demonstrate materials efficiency and reduction in system complexity to help procurement personnel achieve environmental targets.
  • New Technology: Quicker, more accurate, in-line, and process analyses will improve yield, process control and allow for greater flexibility in batch size. Customer requirements for 100% production traceability for critical and sterile components is driving supplier requirements for traceability. Digital records of process controls and quality will enable suppliers to accomplish shorter lead times and charge a premium.

Dependable, quick contract validation based on digital evidence of process controls for infusion systems will drive premium prices. Combining lower environmental impact with standard infusion systems will improve competitive positions. Overall, qualified companies should benefit from a gradual improvement in market position.

EVA Infusion Bag Market Drivers and Challenges

The infusion bag market is changing because of different trends, including the use of more advanced technology, the growing demand for healthcare services, and different rules and regulations. More effective methods for producing biological products, as well as new infusion therapies, are creating a larger market for infusion bags. At the same time, producing infusion bags and meeting various regulations and rules, and addressing environmental concerns, make this a more difficult market. It is important for companies in this market to make infusion products that are effective, safe, and low cost. According to Lucintel, these products will find the most use in the pharmaceutical market, but the clinical and nutritional markets will also see significant growth.

The factors responsible for driving this market include:

  • Customer Interests: The growing need for infusion and injection therapies, particularly for nutrition and biologics, has created more demand for flexible and lightweight infusion bags. The global spending on healthcare was estimated to be over $7 trillion in 2025. With higher spending, more healthcare services are expected to be offered. More infusion services will be needed, especially because of increased chronic health conditions and more home-based healthcare services.
  • Development in Multilayer Films and Seals: The development of multilayer films and seals has revolutionized the manufacturing process of EVA bags. In 2025, advancements in EVA bag technology, in combination with improvements in barrier and sterilization technologies, enabled the production of EVA bags with greater leak-resistance and drug compatibility.
  • Focus on Safety: The concentration on the safety of patients and the requirement of traceability and the need for the packaging to be airtight have created opportunities for the qualified infusion bags. International Standards (ISO) continued to influence the Pharmaceutical Packaging Validation industry. In the next 3 to 5 years, it is expected that the barriers to entry in the industry will increase. Only the most prepared and qualified companies will operate in the industry.
  • Bags and Ports: Improvements in the design of infusion bags has allowed for the production of infusion bags that are better suited for the transport of sensitive medications. Ports have also been redesigned to reduce the amount of air that is trapped in infusion bags. Innovations in the design of infusion bags allowed for the production of bags with a greater range of capacities. The lower limit of this capacity range was reduced to 50 ml. Innovations in the design of infusion bags, along with the growing needs in the areas of Oncology, critical care and other areas, will allow the market for infusion bags to experience growth.
  • Manufacturing Efficiency: Automation, standardized processes, and local production help reduce labour and increase consistency in producing EVA bags. In April 2025, some packaging lines mechanically packaged 100 bags per minute. Over the next 3-5 years, continued automation in packaging would lower the costs of transportation, energy and raw materials. Suppliers would be able to charge lower prices and still maintain a sterile package.

The challenges facing this market include:

  • Raw Material Price Volatility: The first is the price of raw materials. There is a direct relationship between the price of a barrel of oil and EVA resin. Other raw materials including additives, films and components also affect the price of packaging. In March 2025, one barrel of oil was over 60 dollars. The continued volatility of the price of oil would affect the packaging industry. This would result in the use of alternative raw materials, longer-term contracts and increased focus on package optimization.
  • Stringent Compliance Requirements: The second problem is the regulations and testing required for packaging to be used for IV fluids. The requirements for packaging for IV fluids include being sterile, having a long shelf life and not affecting the body negatively. The requirements increase the time and cost for testing and regulatory approval. In the next 5 years, smaller companies would be even further disadvantaged.
  • Disposal Pressure and Environmental Concerns: Because EVA bags are single-use, concerns have been raised about the environment, especially waste disposal and incineration, considering that they are made of plastic and are not easily recyclable. Each year, thousands of tons of different kinds of plastic, including EVA bags, are discarded in various ways by healthcare facilities throughout the world. The lack of a practical alternative will promote research into the development of designs that use other materials, or systems to ease the impact on the environment, during the whole life cycle of the product, including collection and recycling.

Due to demographic changes and advancements in medical technology and sciences, infusion therapies will become more commonplace, as will the use of medical products and services in the patient's domestic environment. Reusable systems and packaging will be developed to address the needs of the aforementioned markets. Though concerns will be raised regarding the safety and affordability of infusion systems and packaging, the environmental impact of infusion systems and packaging will be of primary concern.

List of EVA Infusion Bag Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies eva infusion bag market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the eva infusion bag market companies profiled in this report include-

  • Baxter International
  • B. Braun
  • Fresenius Kabi
  • Weigao Group
  • ICU Medical
  • Metrix
  • Technoflex
  • Bexen Medical
  • Eraser Medical
  • Valmed

EVA Infusion Bag Market by Segment

The study includes a forecast for the global eva infusion bag market by type, application, and region.

EVA Infusion Bag Market by Type [Value ($M) from 2019 to 2035]:

  • Single Chamber
  • Multi Chamber

EVA Infusion Bag Market by Application [Value ($M) from 2019 to 2035]:

  • Hospital
  • Clinic
  • Others

EVA Infusion Bag Market by Region [Value ($M) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the EVA Infusion Bag Market

The eva infusion bag market has been shaped by localization of pharmaceutical supply chains, supply chain resiliency of hospitals and increasing requirements for sterile drug packaging. From 2025 to 2027, most companies will have prioritized and invested in validated polymer systems and manufacturing facilities in regions. According to Lucintel, this situation will create intense market competition in the health care industry.

  • United States: In 2025, the administration implemented a 10% import tariff and Fresenius Kabi opened several pharmaceutical manufacturing facilities in the U.S. As such, U.S. based infusion bag manufacturers would have an advantage over U.S. based importers of resin, and domestic manufacturers of infusion bags over importers.
  • China: In 2025, the China Food and Drug Administration approved 2,289 new medical devices. As such, local manufacturers of infusion systems and parenteral nutrition systems have been developed. Local manufacturers of infusion and parenteral systems, along with the local approval of medical devices, create an environment where Chinese manufacturers of infusion and parenteral systems would be adopted before imported systems.
  • Germany: B. Braun's 2025 investment plan has been disclosed, outlining plans to enhance automated production and logistics at its Melsungen site. The company has been investing to expand its infusion therapy business. This is relevant because Melsungen has the potential to manufacture and consistently supply high-tech, automated EVA film to the pharmaceutical and other industries.
  • India: The Indian government's strategies to localize the production of medical devices, especially through the combination of production-linked incentives and import substitution, are gaining traction. The pharmaceutical industry has benefited from similar policies. The 2025-26 Indian Union Budget allocated funds to further bolster the pharmaceutical sector. These policies have increased the local production of medical devices. Relevant: The local production of infusion bags in India has improved.
  • Japan: Rising demand in pharmaceuticals has led Terumo to boost its 2025 fiscal investment to $672 million. This investment focuses on global manufacturing and R&D. Improving EVA bags has the potential to enhance safe and effective delivery systems for clinical care. Rising automation in the production of EVA bags will provide improving delivery systems for clinical care.

Features of the Global EVA Infusion Bag Market

  • Market Size Estimates: eva infusion bag market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: eva infusion bag market size by type, application, and region in terms of value ($B).
  • Regional Analysis: eva infusion bag market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the eva infusion bag market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the eva infusion bag market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the eva infusion bag market by type (single chamber and multi chamber), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global EVA Infusion Bag Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Single Chamber : Trends and Forecast 2019 to 2035
  • 4.4 Multi Chamber : Trends and Forecast 2019 to 2035

5. Global EVA Infusion Bag Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital : Trends and Forecast 2019 to 2035
  • 5.4 Clinic : Trends and Forecast 2019 to 2035
  • 5.5 Others : Trends and Forecast 2019 to 2035

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global EVA Infusion Bag Market by Region

7. North American EVA Infusion Bag Market

  • 7.1 Overview
  • 7.2 North American EVA Infusion Bag Market by Type
  • 7.3 North American EVA Infusion Bag Market by Application
  • 7.4 The United States EVA Infusion Bag Market
  • 7.5 Canadian EVA Infusion Bag Market
  • 7.6 Mexican EVA Infusion Bag Market

8. European EVA Infusion Bag Market

  • 8.1 Overview
  • 8.2 European EVA Infusion Bag Market by Type
  • 8.3 European EVA Infusion Bag Market by Application
  • 8.4 German EVA Infusion Bag Market
  • 8.5 French EVA Infusion Bag Market
  • 8.6 Italian EVA Infusion Bag Market
  • 8.7 Spanish EVA Infusion Bag Market
  • 8.8 The United Kingdom EVA Infusion Bag Market

9. APAC EVA Infusion Bag Market

  • 9.1 Overview
  • 9.2 APAC EVA Infusion Bag Market by Type
  • 9.3 APAC EVA Infusion Bag Market by Application
  • 9.4 Chinese EVA Infusion Bag Market
  • 9.5 Indian EVA Infusion Bag Market
  • 9.6 Japanese EVA Infusion Bag Market
  • 9.7 South Korean EVA Infusion Bag Market
  • 9.8 Indonesian EVA Infusion Bag Market

10. ROW EVA Infusion Bag Market

  • 10.1 Overview
  • 10.2 ROW EVA Infusion Bag Market by Type
  • 10.3 ROW EVA Infusion Bag Market by Application
  • 10.4 Middle Eastern EVA Infusion Bag Market
  • 10.5 South American EVA Infusion Bag Market
  • 10.6 African EVA Infusion Bag Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global EVA Infusion Bag Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 Baxter International
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 B. Braun
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Fresenius Kabi
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Weigao Group
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 ICU Medical
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Metrix
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Technoflex
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Bexen Medical
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Eraser Medical
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Valmed
    • Company Overview
    • EVA Infusion Bag Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global EVA Infusion Bag Market
  • Figure 2.1: Usage of EVA Infusion Bag Market
  • Figure 2.2: Classification of the Global EVA Infusion Bag Market
  • Figure 2.3: Supply Chain of the Global EVA Infusion Bag Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the EVA Infusion Bag Market
  • Figure 4.1: Global EVA Infusion Bag Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global EVA Infusion Bag Market ($B) by Type
  • Figure 4.3: Forecast for the Global EVA Infusion Bag Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Single Chamber in the Global EVA Infusion Bag Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Multi Chamber in the Global EVA Infusion Bag Market (2019-2035)
  • Figure 5.1: Global EVA Infusion Bag Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global EVA Infusion Bag Market ($B) by Application
  • Figure 5.3: Forecast for the Global EVA Infusion Bag Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global EVA Infusion Bag Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Clinic in the Global EVA Infusion Bag Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Others in the Global EVA Infusion Bag Market (2019-2035)
  • Figure 6.1: Trends of the Global EVA Infusion Bag Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global EVA Infusion Bag Market ($B) by Region (2027-2035)
  • Figure 7.1: Trends and Forecast for the North American EVA Infusion Bag Market (2019-2035)
  • Figure 7.2: North American EVA Infusion Bag Market by Type in 2019, 2026, and 2035
  • Figure 7.3: Trends of the North American EVA Infusion Bag Market ($B) by Type (2019-2026)
  • Figure 7.4: Forecast for the North American EVA Infusion Bag Market ($B) by Type (2027-2035)
  • Figure 7.5: North American EVA Infusion Bag Market by Application in 2019, 2026, and 2035
  • Figure 7.6: Trends of the North American EVA Infusion Bag Market ($B) by Application (2019-2026)
  • Figure 7.7: Forecast for the North American EVA Infusion Bag Market ($B) by Application (2027-2035)
  • Figure 7.8: Trends and Forecast for the United States EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European EVA Infusion Bag Market (2019-2035)
  • Figure 8.2: European EVA Infusion Bag Market by Type in 2019, 2026, and 2035
  • Figure 8.3: Trends of the European EVA Infusion Bag Market ($B) by Type (2019-2026)
  • Figure 8.4: Forecast for the European EVA Infusion Bag Market ($B) by Type (2027-2035)
  • Figure 8.5: European EVA Infusion Bag Market by Application in 2019, 2026, and 2035
  • Figure 8.6: Trends of the European EVA Infusion Bag Market ($B) by Application (2019-2026)
  • Figure 8.7: Forecast for the European EVA Infusion Bag Market ($B) by Application (2027-2035)
  • Figure 8.8: Trends and Forecast for the German EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC EVA Infusion Bag Market (2019-2035)
  • Figure 9.2: APAC EVA Infusion Bag Market by Type in 2019, 2026, and 2035
  • Figure 9.3: Trends of the APAC EVA Infusion Bag Market ($B) by Type (2019-2026)
  • Figure 9.4: Forecast for the APAC EVA Infusion Bag Market ($B) by Type (2027-2035)
  • Figure 9.5: APAC EVA Infusion Bag Market by Application in 2019, 2026, and 2035
  • Figure 9.6: Trends of the APAC EVA Infusion Bag Market ($B) by Application (2019-2026)
  • Figure 9.7: Forecast for the APAC EVA Infusion Bag Market ($B) by Application (2027-2035)
  • Figure 9.8: Trends and Forecast for the Japanese EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW EVA Infusion Bag Market (2019-2035)
  • Figure 10.2: ROW EVA Infusion Bag Market by Type in 2019, 2026, and 2035
  • Figure 10.3: Trends of the ROW EVA Infusion Bag Market ($B) by Type (2019-2026)
  • Figure 10.4: Forecast for the ROW EVA Infusion Bag Market ($B) by Type (2027-2035)
  • Figure 10.5: ROW EVA Infusion Bag Market by Application in 2019, 2026, and 2035
  • Figure 10.6: Trends of the ROW EVA Infusion Bag Market ($B) by Application (2019-2026)
  • Figure 10.7: Forecast for the ROW EVA Infusion Bag Market ($B) by Application (2027-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African EVA Infusion Bag Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global EVA Infusion Bag Market
  • Figure 11.2: Market Share (%) of Top Players in the Global EVA Infusion Bag Market (2026)
  • Figure 12.1: Growth Opportunities for the Global EVA Infusion Bag Market by Type
  • Figure 12.2: Growth Opportunities for the Global EVA Infusion Bag Market by Application
  • Figure 12.3: Growth Opportunities for the Global EVA Infusion Bag Market by Region
  • Figure 12.4: Emerging Trends in the Global EVA Infusion Bag Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the EVA Infusion Bag Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the EVA Infusion Bag Market by Region
  • Table 1.3: Global EVA Infusion Bag Market Parameters and Attributes
  • Table 3.1: Trends of the Global EVA Infusion Bag Market (2019-2026)
  • Table 3.2: Forecast for the Global EVA Infusion Bag Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global EVA Infusion Bag Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global EVA Infusion Bag Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global EVA Infusion Bag Market (2027-2035)
  • Table 4.4: Trends of Single Chamber in the Global EVA Infusion Bag Market (2019-2026)
  • Table 4.5: Forecast for Single Chamber in the Global EVA Infusion Bag Market (2027-2035)
  • Table 4.6: Trends of Multi Chamber in the Global EVA Infusion Bag Market (2019-2026)
  • Table 4.7: Forecast for Multi Chamber in the Global EVA Infusion Bag Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global EVA Infusion Bag Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global EVA Infusion Bag Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global EVA Infusion Bag Market (2027-2035)
  • Table 5.4: Trends of Hospital in the Global EVA Infusion Bag Market (2019-2026)
  • Table 5.5: Forecast for Hospital in the Global EVA Infusion Bag Market (2027-2035)
  • Table 5.6: Trends of Clinic in the Global EVA Infusion Bag Market (2019-2026)
  • Table 5.7: Forecast for Clinic in the Global EVA Infusion Bag Market (2027-2035)
  • Table 5.8: Trends of Others in the Global EVA Infusion Bag Market (2019-2026)
  • Table 5.9: Forecast for Others in the Global EVA Infusion Bag Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global EVA Infusion Bag Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global EVA Infusion Bag Market (2027-2035)
  • Table 7.1: Trends of the North American EVA Infusion Bag Market (2019-2026)
  • Table 7.2: Forecast for the North American EVA Infusion Bag Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American EVA Infusion Bag Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American EVA Infusion Bag Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American EVA Infusion Bag Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American EVA Infusion Bag Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States EVA Infusion Bag Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican EVA Infusion Bag Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian EVA Infusion Bag Market (2019-2035)
  • Table 8.1: Trends of the European EVA Infusion Bag Market (2019-2026)
  • Table 8.2: Forecast for the European EVA Infusion Bag Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European EVA Infusion Bag Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European EVA Infusion Bag Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European EVA Infusion Bag Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European EVA Infusion Bag Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German EVA Infusion Bag Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French EVA Infusion Bag Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish EVA Infusion Bag Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian EVA Infusion Bag Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom EVA Infusion Bag Market (2019-2035)
  • Table 9.1: Trends of the APAC EVA Infusion Bag Market (2019-2026)
  • Table 9.2: Forecast for the APAC EVA Infusion Bag Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC EVA Infusion Bag Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC EVA Infusion Bag Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC EVA Infusion Bag Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC EVA Infusion Bag Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese EVA Infusion Bag Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian EVA Infusion Bag Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese EVA Infusion Bag Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean EVA Infusion Bag Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian EVA Infusion Bag Market (2019-2035)
  • Table 10.1: Trends of the ROW EVA Infusion Bag Market (2019-2026)
  • Table 10.2: Forecast for the ROW EVA Infusion Bag Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW EVA Infusion Bag Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW EVA Infusion Bag Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW EVA Infusion Bag Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW EVA Infusion Bag Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern EVA Infusion Bag Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American EVA Infusion Bag Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African EVA Infusion Bag Market (2019-2035)
  • Table 11.1: Product Mapping of EVA Infusion Bag Suppliers Based on Segments
  • Table 11.2: Operational Integration of EVA Infusion Bag Manufacturers
  • Table 11.3: Rankings of Suppliers Based on EVA Infusion Bag Revenue
  • Table 12.1: New Product Launches by Major EVA Infusion Bag Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global EVA Infusion Bag Market